Quantamental Technologies LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Quantamental Technologies LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$261,000
+7.9%
2,733
+17.6%
0.19%
+55.6%
Q4 2019$242,000
+374.5%
2,323
+420.9%
0.12%
+552.6%
Q2 2019$51,000
-25.0%
446
-11.0%
0.02%
-53.7%
Q4 2018$68,0005010.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders